Security key
890260854
Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP)
CUSIP: 890260854
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 186,616,143
- Total 13F shares
- 14,436,164
- Share change
- +9,840,912
- Total reported value
- $5,809,652
- Price per share
- $0.40
- Number of holders
- 34
- Value change
- +$3,945,317
- Number of buys
- 15
- Number of sells
- 8
Report period
Q4 2023
Institutions
34
Top holders
10
TNXP full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Tonix Pharmaceuticals Holding Corp. SEC filings
Tonix Pharmaceuticals Holding Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 890260854
Recent filing periods:
Top shareholders of TNXP - Tonix Pharmaceuticals Holding Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.78%
|
1,450,000
|
$790,250 | — | 30 Sep 2023 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
1,247,465
|
$679,868 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.21%
|
398,145
|
$216,989 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
223,911
|
$122,000 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
126,297
|
$68,850 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
66,989
|
$37,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
48,358
|
$26,356 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
31,207
|
$17,008 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
20,667
|
$11,264 | — | 30 Sep 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.01%
|
20,122
|
$11,000 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
18,724
|
$10,205 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,305
|
$8,886 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
15,628
|
$8,000 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
9,089
|
$4,954 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
933
|
$509 | — | 30 Sep 2023 | |
| NVWM, LLC |
13F
|
Company |
0%
|
140
|
$76 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
130
|
$71 | — | 30 Sep 2023 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
64
|
$36 | — | 30 Sep 2023 | |
| Focused Wealth Management, Inc |
13F
|
Company |
0%
|
36
|
$20 | — | 30 Sep 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
27
|
$15 | — | 30 Sep 2023 | |
| Beaird Harris Wealth Management, LLC |
13F
|
Company |
0%
|
13
|
$8 | — | 30 Sep 2023 | |
| Gradient Investments LLC |
13F
|
Company |
0%
|
11
|
$6 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
8
|
$5 | — | 30 Sep 2023 | |
| North Star Investment Management Corp. |
13F
|
Company |
0%
|
7
|
$4 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
6
|
$3 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
4
|
$2 | — | 30 Sep 2023 | |
| Global Wealth Strategies & Associates |
13F
|
Company |
0%
|
3
|
$2 | — | 30 Sep 2023 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
2
|
$1 | — | 30 Sep 2023 | |
| HARBOR INVESTMENT ADVISORY, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2023 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2023 | |
| Twin Lakes Capital Management, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2023 | |
| Daniel Wintner Goodman |
3/4/5
|
Director |
—
class O/S missing
|
5,001
|
$8,552 | — | 25 May 2021 |
Institutional Holders of Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP) as of Q4 2023
As of 31 Dec 2023,
Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,436,164 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., MARSHALL WACE, LLP, Rosalind Advisors, Inc., Altium Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
29
Q4 2023 holders
34
Holder diff
5
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.